Search
for

    Sort by

    Community Join

    990-1000 / 1000+ results

      community Fin/min/derma/niz 8 month update

      in Progress Pictures 4 years ago
      Hair loss treatments, including the use of Minoxidil and Finasteride, with a user sharing their 8-month update on progress made. Others have chimed in to provide encouragement and advice for continued treatment.

      community HT - Currently 19 days Post-OP

      in Progress Pictures  7 upvotes 1 month ago
      A 30-year-old male, 19 days post-hair transplant, is experiencing normal shedding and is concerned about hair loss. He is taking Dutasteride and Minoxidil tablets daily and is advised to trust the process as shedding is a typical phase.

      community Minor hair transplant, 805 grafts

      in Transplants  4 upvotes 3 years ago
      User had minor hair transplant in 2020, used Fin since 2008, Min since 2014, and added microneedling in 2022. Routine was irregular with no severe effects.
      What is my approximate norwood level?

      community What is my approximate norwood level?

      in General  36 upvotes 9 months ago
      The user is likely at Norwood level 3 with thinning at the crown and temple recession. Treatments like finasteride or minoxidil are suggested to manage hair loss.

      community 2nd HT FOR CROWN AND MID SCALP.

      in Transplants  2 upvotes 8 months ago
      The user underwent a second hair transplant for the crown and mid-scalp, achieving good density. They are using minoxidil, finasteride, and biotin, and considering PRP treatments to enhance growth.

      community HMI-115 question about potential earliest access

      in Research/Science  10 upvotes 3 years ago
      Hair loss treatments discussed include Minoxidil, Finasteride, and RU58841. HMI-115, a monoclonal antibody drug, is in phase 1 and 2 trials for different conditions, but its availability on the gray market is unlikely due to high production costs.

      community GT20029 China Phase II Trial For AGA Reached Primary Endpoint

      in Research/Science  133 upvotes 2 years ago
      The GT20029 tincture, a topical androgen receptor degrader, showed significant hair growth and good safety in a China Phase II trial for male androgenetic alopecia (AGA), with the 1% dose twice weekly identified as optimal. The company plans to initiate Phase III trials in China and Phase II in the U.S., and the treatment also shows promise for acne.